- Home
- Publications
- Publication Search
- Publication Details
Title
Improving vaccine trials in infectious disease emergencies
Authors
Keywords
-
Journal
SCIENCE
Volume 357, Issue 6347, Pages 153-156
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-07-20
DOI
10.1126/science.aam8334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccine testing for emerging infections: the case for individual randomisation
- (2017) Nir Eyal et al. JOURNAL OF MEDICAL ETHICS
- CEPI—a new global R&D organisation for epidemic preparedness and response
- (2017) Børge Brende et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Drop in cases of Zika threatens large-scale trials
- (2017) Declan Butler NATURE
- Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone
- (2017) A. Camacho et al. VACCINE
- Using simulation to aid trial design: Ring-vaccination trials
- (2017) Matt David Thomas Hitchings et al. PLoS Neglected Tropical Diseases
- Zika Virus Transmission — Region of the Americas, May 15, 2015–December 15, 2016
- (2017) Juniorcaius Ikejezie et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Ethical Rationale for the Ebola “Ring Vaccination” Trial Design
- (2016) Annette Rid et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis
- (2016) Marco Ajelli et al. BMC Medicine
- Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
- (2016) Cameron Griffiths et al. CLINICAL MICROBIOLOGY REVIEWS
- Leveraging contact network structure in the design of cluster randomized trials
- (2016) Guy Harling et al. Clinical Trials
- Decoding the human immune system to transform the future of global disease prevention and control
- (2016) Wayne C. Koff et al. Expert Review of Vaccines
- Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies
- (2016) Marc Lipsitch et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Adaptive Designs for Clinical Trials
- (2016) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zika and the Risk of Microcephaly
- (2016) Michael A. Johansson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Yellow fever emergency forces officials to combat virus with tiny dose of vaccine
- (2016) Kai Kupferschmidt SCIENCE
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure — United States, September 2016
- (2016) Emily E. Petersen et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis
- (2015) Steven E Bellan et al. LANCET INFECTIOUS DISEASES
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccinology in the era of high-throughput biology
- (2015) H. I. Nakaya et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- As Ebola wanes, trials jockey for patients
- (2015) K. Kupferschmidt SCIENCE
- Ebola and beyond
- (2015) M. Lipsitch et al. SCIENCE
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- (2015) BMJ-British Medical Journal
- Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
- (2015) Ben S. Cooper et al. PLOS MEDICINE
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- (2015) BMJ-British Medical Journal
- Ebola Virus Disease — Sierra Leone and Guinea, August 2015
- (2015) Sara Hersey et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evaluating Novel Therapies During the Ebola Epidemic
- (2014) Steven Joffe JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ethical considerations of experimental interventions in the Ebola outbreak
- (2014) Annette Rid et al. LANCET
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery
- (2013) Vance G. Fowler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk in Vaccine Research and Development Quantified
- (2013) Esther S. Pronker et al. PLoS One
- Efficacy Results of a Trial of a Herpes Simplex Vaccine
- (2012) Robert B. Belshe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive Trial Design: Could We Use This Approach to Improve Clinical Trials in the Field of Global Health?
- (2011) Trudie Lang AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
- (2011) Mary S. Campbell et al. PLoS One
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started